Solid Biosciences Inc. (SLDB) Financials

SLDB Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 164.9 million 38.5 million
2023-09-30 184.7 million 40.4 million
2023-06-30 204.7 million 41.0 million
2023-03-31 229.6 million 45.8 million

SLDB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -20.9 million 1.9 million
2023-09-30 -18.3 million 1.6 million
2023-06-30 -28.0 million 1.9 million
2023-03-31 -28.5 million 2.1 million

SLDB Net Income

No data available :(

SLDB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 123.6 million - 26.3 million
2023-09-30 142.9 million - 26.8 million
2023-06-30 160.2 million - 27.4 million
2023-03-31 185.5 million - 27.8 million

SLDB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 20.4 million
2023-09-30 20.1 million
2023-06-30 19.7 million
2023-03-31 19.6 million

SLDB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 90000 15.5 million 6.8 million 587000
2023-09-30 383000 16.7 million 6.4 million -
2023-06-30 536000 19.8 million 7.1 million -
2023-03-31 506000 24.6 million 7.4 million -

SLDB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 587000
2023-09-30 - 588000
2023-06-30 - 703000
2023-03-31 - 1.1 million

SLDB

Price: $10.10

52 week price:
1.81
15.05

Earnings Per Share: -4.83 USD

P/E Ratio: 0.10

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 27300

Market Capitalization: 378.9 million

Links: